A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma-Reference-Cited by-同舟云学术

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

Published:2010-01-16 Issue:3 Volume:29 Page:489-498
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Hersh Evan M.,O’Day Steven J.,Powderly John,Khan Khuda D.,Pavlick Anna C.,Cranmer Lee D.,Samlowski Wolfram E.,Nichol Geoffrey M.,Yellin Michael J.,Weber Jeffrey S.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-009-9376-8.pdf

Reference32 articles.

1. Lens MB, Dawes M (2004) Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 150:179–185

2. Cancer Facts & Figures (2009) American cancer society, Atlanta, GA, USA. http://www.cancer.org/downloads/STT/2009CAFFfinalsecured.pdf Accessed August 31st, 2009

3. Korn EL, Liu PY, Lee SJ et al (2008) Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. J Clin Oncol 26:527–534

4. Bedikian AY, Millward M, Pehamberger H et al (2006) Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the oblimersen melanoma study group. J Clin Oncol 24:4738–4745

5. Agarwala SS (2009) Current systemic therapy for metastatic melanoma. Expert Rev Anticancer Ther 9:587–595

Cited by 259 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitors: Fundamental Mechanisms, Current Status and Future Directions;Immuno;2024-07-05

2. Combination Therapy with Immune Checkpoint Inhibitors and Histone Deacetylase Inhibitors or Alkylating Agents;Cancer Management and Research;2024-07

3. Is There a Current Role for Combination Chemotherapy or High-Dose Interleukin 2 in Melanoma?;The Cancer Journal;2024-03

4. Is pancreaticoduodenectomy justified for metastatic melanoma to the ampulla of Vater?;2024-01-18

5. Incidence of Cutaneous Immune-Related Adverse Events and Outcomes in Immune Checkpoint Inhibitor-Containing Regimens: A Systematic Review and Meta-Analysis;Cancers;2024-01-13